Amber
3 known investors
Amber Bio is a biotechnology company developing a novel RNA writing platform capable of multi-kilobase gene edits that can treat multiple mutations across patients with a single product.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
JB
Jacob Borrajo, PhDFounder and CEO
Investors · 3
Competitors · 6
by search overlapTransition Bio10 shared keywordsTransition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease. The company is a platform-based biotherapeutics developer founded on academic research from the University of Cambridge.
Bridgebio10 shared keywordsBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
Amber Therapeutics9 shared keywordsAmber Therapeutics develops medical technology focused on treating mixed urinary incontinence, advancing toward pivotal clinical trials in the US with expanded feasibility studies in Europe.
Engage Bio9 shared keywordsEngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.
Cambrian Bio8 shared keywordsCambrian Biopharma develops medicines targeting metabolic pathways that decline with age, aiming to treat and eventually prevent chronic metabolic disease and extend healthspan. It operates a drug sourcing and development model that advances a portfolio of drug candidates across multiple pipeline programs.
bio8 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
Companies competing with Amber for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Amber do?
- Amber Bio is a biotechnology company developing a novel RNA writing platform capable of multi-kilobase gene edits that can treat multiple mutations across patients with a single product.
- Who founded Amber?
- Amber was founded by Jacob Borrajo, PhD.
- Who are Amber's investors?
- Amber's investors include Playground Global, Andreessen Horowitz, Hummingbird Ventures.